Webinar - Navigating IND Filings: Key Strategies for Early-Stage Drug Development Success

With 13 years of experience in drug discovery and development, William Lian has specialized expertise in Computer-Aided Drug Design (CADD), generic drug development, and investigational new drugs (IND). William has managed 60+ projects for over 40 clients, advancing innovation in pharmaceutical development. He has over 8 years of regulatory affairs experience, with a focus on China, the US, the EU, Taiwan, ASEAN, Korea, and Japan.
William holds a B.S. in Chemistry from National Tsing Hua University (Taiwan) and is a PhD Candidate in Molecular Medicine at the same institution. After joining BioDuro-Sundia in 2018, he oversees regulatory compliance and project management. His previous experience includes leading the Quality Assurance Department at Tai-Yu Chemical and Pharmaceutical Co. Ltd., where he was the primary responder for PIC/S GMP, GDP, and medical device audits.
As a certified Project Management Professional (PMP®) and Certified Quality Technician (CQT), William has demonstrated strong leadership, communication, and project management skills. His experience includes managing GMP processes, responding to audits, and focus on regulatory compliance and quality assurance.